U.S. Patent No. 12,036,174
`Declaration of Morten O. Jensen, PhD, DrMed
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________________________________
`
`
`
`
`THERABODY, INC.
`Petitioner
`
`
`v.
`
`DATAFEEL INC.
`Patent Owner.
`
`
`_________________________
`
`Case No. PGR2025-00026
`U.S. Patent No. 12,036,174
`_________________________
`
`
`DECLARATION OF MORTEN O. JENSEN, PhD, DrMed
`IN SUPPORT OF PETITION FOR POST GRANT REVIEW
`OF U.S. PATENT NO. 12,036,174
`
`
`
`
`
`
`
`
`Petitioner Therabody Ex-1002, 0001
`
`

`

`TABLE OF CONTENTS
`
`
`Page
`
`
`I. 
`
`II. 
`
`INTRODUCTION .......................................................................................... 1 
`A.  Qualifications and Experience ............................................................. 2 
`B.  MATERIALS CONSIDERED ............................................................. 7 
`RELEVANT LEGAL STANDARDS .......................................................... 10 
`A.  Anticipation ........................................................................................ 10 
`B. 
`Obviousness ........................................................................................ 11 
`C.  Written Description ............................................................................ 14 
`D. 
`Enablement ......................................................................................... 15 
`E. 
`Indefiniteness ...................................................................................... 15 
`F. 
`Level of Ordinary Skill in the Art ...................................................... 16 
`G. 
`Claim Construction ............................................................................ 17 
`SUMMARY OF GROUNDS ....................................................................... 19 
`III. 
`IV.  THE ’174 PATENT ...................................................................................... 19 
`A.  Overview of the ’174 Patent ............................................................... 19 
`B. 
`The Priority Date for the ’174 Patent ................................................. 29 
`C. 
`Prosecution History of the ’174 Patent .............................................. 30 
`D. 
`The State of the Art ............................................................................ 31 
`1. 
`Alternate Communication Devices .......................................... 31 
`2.  Massage Treatment Devices .................................................... 35 
`3. 
`Biometric Sensors .................................................................... 38 
`The Challenged Claims ...................................................................... 39 
`E. 
`V.  OVERVIEW OF PRIOR ART ..................................................................... 40 
`A.  Korean Unexamined Application Publication No. 10-2001-
`0008111 (“Lee”) (Ex-1005) ............................................................... 40 
`U.S. Patent Application Publication No. 2016/0310353
`(“Barasch”) (Ex-1007) ....................................................................... 44 
`C. Korean Patent No.10-1123926 (“Choi”) (Ex-1008) ...................... 48 
`
`B. 
`
`C. 
`
`i
`
`Petitioner Therabody Ex-1002, 0002
`
`

`

`
`
`VI. 
`
`TABLE OF CONTENTS
`(continued)
`
`Page
`
`2. 
`
`c. 
`
`D.  U.S. Patent No. 7,384,405 (“Rhoades”) (Ex-1010) ........................... 51 
`E. 
`U.S. Patent Application Publication No. 2015/0305969
`(“Giraud”) (Ex-1011) ......................................................................... 54 
`INVALIDITY OF THE ’174 PATENT IN VIEW OF PRIOR ART .......... 58 
`A.  Ground 1: Claims 1-3, 5-6, 8-19 Are Unpatentable Under 35
`U.S.C. § 103 As Obvious Over Lee in View of Barasch. .................. 58 
`1. 
`A POSITA Would Have Been Motivated to Combine
`Lee’s Teachings With Barasch and Would Have Had a
`Reasonable Expectation of Success. ........................................ 58 
`Independent Claim 1 ................................................................ 63 
`a. 
`Element 1[pre]: “A treatment device, comprising:” ...... 63 
`b. 
`Element 1[a]: “a body provided with a processing
`unit and a power source; and” ....................................... 63 
`Element 1[b]: “a plurality of energy generator
`elements being independently operable to convert
`electricity from the power source into a plurality of
`different energy types transmittable towards an
`area of skin of a user, the plurality of energy
`generator elements being arranged coaxially about
`an axis,” ......................................................................... 65 
`Element 1[c]: “wherein the body includes a grip
`arranged to be grasped by a hand of the user
`applying a gripping force to maintain the plurality
`of energy generator elements on or adjacent the
`area of skin,” .................................................................. 68 
`Element 1[d]: “wherein the plurality of energy
`generator elements includes a first energy
`generator element and a second energy generator
`element, and wherein the first energy generator
`element is an impact generator element having a
`tissue contact surface that is linearly actuatable
`along the axis to contact and cause corresponding
`physical movement of the area of skin.” ....................... 70 
`
`d. 
`
`e. 
`
`ii
`
`Petitioner Therabody Ex-1002, 0003
`
`

`

`
`
`3. 
`
`4. 
`
`5. 
`
`6. 
`
`7. 
`
`TABLE OF CONTENTS
`(continued)
`
`Page
`
`Claim 2: “The treatment device of claim 1, wherein the
`impact generator element further
`includes a drive
`mechanism and a piston, wherein the drive mechanism is
`operably coupled to a controller that directs electricity to
`the drive mechanism to move the piston and the tissue
`contact surface along the axis.” ............................................... 71 
`Claim 3: “The treatment device of claim 1, wherein the
`second energy generator element is substantially ring
`shaped and arranged coaxially about the first energy
`generator element.” .................................................................. 73 
`Claim 5: “The treatment device of claim 1, wherein the
`second energy generator element includes a heat generator
`element.” .................................................................................. 74 
`Claim 6: “The treatment device of claim 1, wherein a first
`one of the plurality of different energy types is an impact
`force applied against a surface of the area of skin and a
`second one of the plurality of different energy types is a
`heat flux directed toward the area of skin.” ............................. 75 
`Independent Claim 8 ................................................................ 76 
`a. 
`Element 8[pre]: “A treatment device, comprising:” ...... 76 
`b. 
`Element 8[a]: “a body provided with a sensor, a
`power source, and a processing unit configured to
`receive input data and generate a control signal
`based on the input data, the body further including
`a skin contacting surface maintainable against skin
`of a user by a force applied by a hand of the user
`when gripping the body; and” ....................................... 77 
`
`iii
`
`Petitioner Therabody Ex-1002, 0004
`
`

`

`TABLE OF CONTENTS
`(continued)
`
`Page
`
`
`
`8. 
`
`9. 
`
`c. 
`
`d. 
`
`Element 8[b]: “a first energy generator element
`and a second energy generator element coupled to
`the body, the first and second energy generator
`elements being independently operable to convert
`electricity from the power source into a first
`energy type and a second energy type,
`respectively, and direct the first and second energy
`types toward an area of skin, the first energy
`generator element including an impact generator
`element having a tissue contact surface that is
`linearly actuatable along an axis to contact and
`cause corresponding physical movement of the
`area of skin,” .................................................................. 79 
`Element 8[c]: “wherein the sensor is configured to
`detect additional input data based on a vital sign of
`the user and transmit the input data for display” ........... 81 
`Claim 9: “The treatment device of claim 8, wherein the
`additional input data corresponds to a heart rate of the
`user.” ........................................................................................ 84 
`Claim 10: “The treatment device of claim 8, further
`comprising a controller configured to modify intensity of
`the first energy type and the second energy type.” .................. 84 
`10.  Claim 11: “The treatment device of claim 8, wherein a
`portion of the body configured to be gripped by the hand
`of the user is configured to emulate a grip of a gun.” .............. 85 
`11.  Claim 12: “The treatment device of claim 8, wherein the
`impact generator element further
`includes a drive
`mechanism and a piston, wherein the drive mechanism is
`operably coupled to a controller to direct electricity to the
`drive mechanism and move the piston and the tissue
`contacting surface along the axis.” .......................................... 86 
`12.  Claim 13: “The treatment device of claim 12, wherein the
`second energy generator element is a heat generator
`element configured to output the second energy type
`
`iv
`
`Petitioner Therabody Ex-1002, 0005
`
`

`

`
`
`TABLE OF CONTENTS
`(continued)
`
`Page
`
`including a heat flux toward the area of skin.” ........................ 86 
`13.  Claim 14: “The treatment device of claim 13, wherein the
`heat generator element is arranged coaxially about the axis
`and at least a portion of the heat generator element extends
`about at least portion of the piston.” ........................................ 87 
`14.  Claim 15: “The treatment device of claim 13, further
`comprising
`a
`third
`energy
`generator
`element
`independently operable of the first and second energy
`generator elements to output a third energy type toward
`the area of skin.” ...................................................................... 88 
`15.  Claim 16: “The treatment device of claim 15, further
`comprising a controller configured to modify an intensity
`of the first, second, and third energy types.” ........................... 89 
`Independent Claim 17 .............................................................. 89 
`a. 
`Element 17[pre]: “A treatment device,
`comprising:” .................................................................. 89 
`Element 17[a]: “a body provided with a power
`source and a processing unit configured to receive
`input data and generate a control signal based on
`the input data, the body including a skin contacting
`surface maintainable against skin of a user by a
`force applied by a hand of the user when gripping
`the body; and” ................................................................ 90 
`
`16. 
`
`b. 
`
`v
`
`Petitioner Therabody Ex-1002, 0006
`
`

`

`
`
`B. 
`
`TABLE OF CONTENTS
`(continued)
`
`Page
`
`c. 
`
`d. 
`
`Element 17[b]: “a first energy generator element
`and a second energy generator element coupled to
`the body, the first and second energy generator
`elements being independently operable to convert
`electricity from the power source into a first
`energy type and a second energy type,
`respectively, and direct the first and second energy
`types toward an area of skin, the first energy
`generator element including an impact generator
`element having a tissue contact surface that is
`linearly actuatable along an axis to contact and
`cause corresponding physical movement of the
`area of skin;” .................................................................. 91 
`Element 17[c]: “wherein the processing unit is
`operable to output an optical signal on a display
`that is observable by eyes of the user, the output
`corresponding to the control signal.” ............................. 92 
`17.  Claim 18: “The treatment device of claim 17, wherein a
`portion of the body configured to be gripped by the hand
`of the user is configured to emulate a grip of a gun.” .............. 93 
`18.  Claim 19: “The treatment device of claim 17, further
`comprising a sensor to detect additional input data based
`on a vital sign of the user, the additional input data
`corresponding to a heart rate of the user.” ............................... 93 
`Ground 2: Claim 4 is Unpatentable Under 35 U.S.C. § 103 As
`Obvious Over Lee in View of Barasch and further in view of
`Choi. ................................................................................................... 93 
`1. 
`A POSITA Would Have Been Motivated to Combine
`Choi’s Teachings with the Combination of Lee and
`Barasch and Would Have Had a Reasonable Expectation
`of Success. ................................................................................ 94 
`Claim 4: “The treatment device of claim 1, wherein the
`second energy generator element includes a reflecting
`groove circumferentially arranged about the axis, the
`
`2. 
`
`vi
`
`Petitioner Therabody Ex-1002, 0007
`
`

`

`TABLE OF CONTENTS
`(continued)
`
`Page
`
`
`
`C. 
`
`reflecting groove defining a concave shape arranged to
`reflect energy generated from the second energy generator
`element towards the area of skin.” ........................................... 97 
`Ground 3: Claim 7 is Unpatentable Under 35 U.S.C. § 103 As
`Obvious Over Lee in View of Barasch and further in view of
`Rhoades. ............................................................................................. 99 
`1. 
`A POSITA Would Have Been Motivated to Combine
`Lee’s and Barasch’s Teachings With Rhoades and Would
`Have Had a Reasonable Expectation of Success. .................... 99 
`Claim 7: “The treatment device of claim 1, wherein at least
`one of the plurality of energy generator elements is
`contained at least partially within a housing that is
`removably securable to the body.” ........................................ 102 
`D.  Ground 4: Claims 1-7 and 17-18 Are Unpatentable Under 35
`U.S.C. § 103 As Obvious Over Giraud in View of Choi. ................ 103 
`1. 
`A POSITA Would Have Been Motivated to Combine
`Giraud’s and Choi’s Teachings and Would Have Had a
`Reasonable Expectation of Success. ...................................... 103 
`Independent Claim 1 .............................................................. 106 
`a. 
`Element 1[pre]: “A treatment device, comprising:” .... 106 
`b. 
`Element 1[a]: “a body provided with a processing
`unit and a power source; and” ..................................... 107 
`Element 1[b]: “a plurality of energy generator
`elements being independently operable to convert
`electricity from the power source into a plurality of
`different energy types transmittable towards an
`area of skin of a user, the plurality of energy
`generator elements being arranged coaxially about
`an axis,” ....................................................................... 108 
`
`2. 
`
`2. 
`
`c. 
`
`vii
`
`Petitioner Therabody Ex-1002, 0008
`
`

`

`
`
`3. 
`
`4. 
`
`5. 
`
`6. 
`
`7. 
`
`TABLE OF CONTENTS
`(continued)
`
`Page
`
`e. 
`
`d. 
`
`Element 1[c]: “wherein the body includes a grip
`arranged to be grasped by a hand of the user
`applying a gripping force to maintain the plurality
`of energy generator elements on or adjacent the
`area of skin,” ................................................................ 110 
`Element 1[d]: “wherein the plurality of energy
`generator elements includes a first energy
`generator element and a second energy generator
`element, and wherein the first energy generator
`element is an impact generator element having a
`tissue contact surface that is linearly actuatable
`along the axis to contact and cause corresponding
`physical movement of the area of skin.” ..................... 111 
`Claim 2: “The treatment device of claim 1, wherein the
`impact generator element further
`includes a drive
`mechanism and a piston, wherein the drive mechanism is
`operably coupled to a controller that directs electricity to
`the drive mechanism to move the piston and the tissue
`contact surface along the axis.” ............................................. 113 
`Claim 3: “The treatment device of claim 1, wherein the
`second energy generator element is substantially ring
`shaped and arranged coaxially about the first energy
`generator element.” ................................................................ 115 
`Claim 4: “The treatment device of claim 1, wherein the
`second energy generator element includes a reflecting
`groove circumferentially arranged about the axis, the
`reflecting groove defining a concave shape arranged to
`reflect energy generated from the second energy generator
`element towards the area of skin.” ......................................... 116 
`Claim 5: “The treatment device of claim 1, wherein the
`second energy generator element includes a heat generator
`element.” ................................................................................ 117 
`Claim 6: “The treatment device of claim 1, wherein a first
`one of the plurality of different energy types is an impact
`
`viii
`
`Petitioner Therabody Ex-1002, 0009
`
`

`

`
`
`8. 
`
`9. 
`
`TABLE OF CONTENTS
`(continued)
`
`Page
`
`b. 
`
`c. 
`
`force applied against a surface of the area of skin and a
`second one of the plurality of different energy types is a
`heat flux directed toward the area of skin.” ........................... 117 
`Claim 7: “The treatment device of claim 1, wherein at least
`one of the plurality of energy generator elements is
`contained at least partially within a housing that is
`removably securable to the body.” ........................................ 118 
`Independent Claim 17 ............................................................ 120 
`a. 
`Element 17[pre]: “A treatment device,
`comprising:” ................................................................ 120 
`Element 17[a]: “a body provided with a power
`source and a processing unit configured to receive
`input data and generate a control signal based on
`the input data, the body including a skin contacting
`surface maintainable against skin of a user by a
`force applied by a hand of the user when gripping
`the body; and” .............................................................. 120 
`Element 17[b]: “a first energy generator element
`and a second energy generator element coupled to
`the body, the first and second energy generator
`elements being independently operable to convert
`electricity from the power source into a first
`energy type and a second energy type,
`respectively, and direct the first and second energy
`types toward an area of skin, the first energy
`generator element including an impact generator
`element having a tissue contact surface that is
`linearly actuatable along an axis to contact and
`cause corresponding physical movement of the
`area of skin;” ................................................................ 122 
`Element 17[c]: “wherein the processing unit is
`operable to output an optical signal on a display
`that is observable by eyes of the user, the output
`corresponding to the control signal.” ........................... 123 
`
`d. 
`
`ix
`
`Petitioner Therabody Ex-1002, 0010
`
`

`

`TABLE OF CONTENTS
`(continued)
`
`Page
`
`B. 
`
`
`
`VII. 
`
`10.  Claim 18: “The treatment device of claim 17, wherein a
`portion of the body configured to be gripped by the hand
`of the user is configured to emulate a grip of a gun.” ............ 124 
`INVALIDITY OF THE ’174 PATENT CLAIMS UNDER 35 U.S.C.
`§ 112 ........................................................................................................... 125 
`A.  Ground 5: Claims 1-19 Are Unpatentable Under 35 U.S.C. § 112
`For Lack of Written Description Support in the Specification. ....... 125 
`Ground 6: Claims 1-19 Are Unpatentable Under 35 U.S.C. § 112
`Based on Lack of Enablement. ......................................................... 128 
`CONCLUSION ..................................................................................................... 130 
`
`
`x
`
`Petitioner Therabody Ex-1002, 0011
`
`

`

`I.
`
`U.S. Patent No. 12,036,174
`Declaration of Morten O. Jensen, PhD, DrMed
`
`INTRODUCTION
`1.
`I have been retained as an expert witness by the law firm of O’Melveny
`
`& Myers LLP, counsel for Petitioner Therabody, Inc. (“Therabody” or “Petitioner”),
`
`as an independent expert in this proceeding before the Patent Trial and Appeal Board
`
`(“PTAB” or “Board”).
`
`2.
`
`I understand that Therabody is requesting that the Board institute a post
`
`grant review (“PGR”) proceeding of Claims 1-19 of U.S. Patent No. 12,036,174
`
`(“the ’174 Patent”) (Ex-1001), currently assigned to DataFeel Inc. (“PO”).
`
`3.
`
`I am not and have never been an employee of Therabody. WIT Legal,
`
`LLC is being compensated at my usual and customary rate of $850 per hour. No
`
`part of my compensation depends on the outcome of this proceeding, and I have no
`
`other interest in this proceeding.
`
`4.
`
`I have been asked to provide my independent analysis of Claims 1-19
`
`of the ’174 Patent in light of the prior art publications cited below. I have also been
`
`asked to provide my independent analysis of Claims 1-19 of the ’174 Patent and
`
`whether they satisfy the requirements of 35 U.S.C. §§ 112. I have also been asked
`
`to consider the state of the art and prior art available as of October 23, 2017. It is
`
`my opinion that Claims 1-19 of the ’174 Patent are unpatentable for the reasons
`
`provided below.
`
`1
`
`Petitioner Therabody Ex-1002, 0012
`
`

`

`U.S. Patent No. 12,036,174
`Declaration of Morten O. Jensen, PhD, DrMed
`This declaration summarizes the opinions I have formed to date. I
`
`5.
`
`reserve the right to modify my opinions, if necessary, based on further review and
`
`analysis of information that I receive subsequent to the filing of this declaration,
`
`including in response to positions taken by Hyper Ice, Inc., or its expert that I have
`
`not yet seen.
`
`A. Qualifications and Experience
`6.
`A copy of my curriculum vitae (CV) including a list of my publications
`
`is attached hereto as Ex-1003.
`
`7.
`
`I graduated with honors from The Engineering College of Aarhus in
`
`Denmark in July 1997 with a B.Sc. (bachelor's) degree in electrical and computer
`
`engineering with a focus in biomedical engineering. Biomedical based system
`
`automation, signal processing, data acquisition, and control was a large part of my
`
`early education. I graduated from the Georgia Institute of Technology and Emory
`
`University School of Medicine (joint program) in May 2000 with a M.Sc. (master's)
`
`degree in biomedical engineering. I graduated from the University of Aarhus School
`
`of Medicine in Denmark in November 2008 with a Ph.D (doctorate) in medicine. In
`
`March 2015, I was granted a Dr.Med (or dr.med.) in medical science from the
`
`University of Aarhus School of Medicine in Denmark. The Dr.Med degree is a
`
`higher-level doctorate degree that is awarded at certain universities in Northern
`
`Europe in the field of medicine. Dr. Med. is by law a higher degree than the Ph.D
`
`2
`
`Petitioner Therabody Ex-1002, 0013
`
`

`

`U.S. Patent No. 12,036,174
`Declaration of Morten O. Jensen, PhD, DrMed
`(https://en.wikipedia.org/wiki/Doctor_Medicinae_(Danish_and_Norwegian_degree
`
`)). The Dr.Med degree is awarded after a candidate's research and publications have
`
`proven to make a significant difference in the advancement of science. Historically,
`
`the Dr.Med degree has been given only to medical doctors, with rare exceptions. I
`
`was the third engineer in Denmark since 1479 to receive this degree.
`
`8.
`
`From 2000 to 2005 I worked in industry with a company based in
`
`Austin, Texas called National Instruments. Most of my activities with the company
`
`were with the consulting services department. The company makes sophisticated
`
`engineering tools for signal measurement, automation and processing + controls
`
`systems to a large variety of industries. These systems are typically sensor
`
`measurements and physical output, electrically controlled by software, embedded
`
`into a microcontroller or based on a computer. The systems often control mechanical
`
`systems and actuators that are interfacing with the human body.
`
`9.
`
`I am currently employed as Associate Professor of Biomedical
`
`Engineering at the University of Arkansas in Fayetteville, Arkansas. I have held this
`
`position since August 2015. I am also a Scholar of the Arkansas Research Alliance,
`
`a public-private partnership dedicated to elevating a fundamental belief that
`
`"research matters." This Alliance provides financial support for my research at the
`
`university in the field of increasing the understanding of the tissue and fluid
`
`3
`
`Petitioner Therabody Ex-1002, 0014
`
`

`

`U.S. Patent No. 12,036,174
`Declaration of Morten O. Jensen, PhD, DrMed
`mechanics of disease and intervention while creating solutions and dedicated
`
`devices.
`
`10. My opinions in this declaration are mine as an individual and an
`
`independent expert and not those of the University of Arkansas.
`
`11.
`
`I also hold Adjunct Associate Professorships at the University of
`
`Arkansas for Medical Sciences (UAMS) and the University Hospital of Aarhus in
`
`Denmark where I teach biomedical engineering to MD/PhD students and advise on
`
`research projects. I have held these positions since July 2009 (DK) and June 2023
`
`(UAMS) . In 2013-2014, I was an Honorary Clinical Fellow and Senior Lecturer at
`
`University College in London, England.
`
`12. Over the past two decades, I have developed and taught numerous
`
`courses at both the undergraduate and graduate level, as well as in medical schools,
`
`in the field of biomedical engineering, including biomechanics, sensors, actuators,
`
`signals, pressure measurements, biodynamics and biomechanical modeling,
`
`including processing of signals, and control of actuators and systems. As set forth
`
`on my CV (Ex-1003 attached hereto), I have published numerous articles relating to
`
`aspects of device interactions with the soft tissues of the human body, including
`
`device design, performance and specific features that allow them to function
`
`optimally. I have also received numerous awards for my research work, both
`
`nationally and internationally.
`
`4
`
`Petitioner Therabody Ex-1002, 0015
`
`

`

`U.S. Patent No. 12,036,174
`Declaration of Morten O. Jensen, PhD, DrMed
`13. Observation and participation during clinical procedures and treatment
`
`is part of my biomedical research work directed to medical device design and
`
`development. Understanding the biomechanical and device related activities
`
`surrounding these procedures and treatments has given me a first-hand experience
`
`that would only be relevant after obtaining a deep knowledge of the involved physics
`
`and physiologies interacting during the procedures. I consider these experiences
`
`highly relevant, and hence, I have extensive knowledge of the human anatomy at
`
`large, and how tissues, nerves, and blood interact with devices and fluids, both
`
`implanted and externally operated devices through or on the skin.
`
`14.
`
`I have also served on various committees and boards and am still
`
`serving on many of them. This includes review panels such as the National Institutes
`
`of Health (NIH) RO1 Bioengineering, Technology and Surgical Sciences Study
`
`Section panel, Center for Scientific Review (CSR), as well as the National Science
`
`Foundation (NSF) Small Business Innovation Research (SBIR) and Small Business
`
`Technology Transfer (STTR) Medical Devices programs review panel member in
`
`the "Implantables & General Medical Devices" section, panel subsections including
`
`Implantables and Procedures, General Devices, Rehabilitation, Diagnostics,
`
`Instrumentation, Externals, Wearables, Sensors, Medical Technology (materials,
`
`manufacturing).
`
`5
`
`Petitioner Therabody Ex-1002, 0016
`
`

`

`U.S. Patent No. 12,036,174
`Declaration of Morten O. Jensen, PhD, DrMed
`In total, I have been awarded more than $4.7M in funding for my
`
`15.
`
`research from the NIH, NSF, DoD, and non-federal state and private foundations.
`
`16. As a result of my research work, thus far, I have published 102 peer
`
`reviewed publications (hereof 75 journal papers), 20 magazine articles, 11
`
`books/book chapters, 7 conference keynote addresses, and given more than 170
`
`presentations at conferences and seminars. Some of these publications are with the
`
`FDA, as outlined in my CV. I am also an inventor and/or co-inventor of 9 patents /
`
`patent application publications / trade secrets. Communicating my work to the public
`
`is important, and I also have more than 120 Public Media Appearances.
`
`17.
`
`I should note that one of my research partners at my laboratory at the
`
`University of Arkansas is my wife, Dr. Hanna Jensen, who is a Medical Doctor (MD)
`
`with Ph.D and Dr.Med degrees. Dr. Hanna Jensen has practiced surgery in multiple
`
`countries in Europe for more than half a decade. She was also performing general
`
`practice in her hometown in Finland, as well as clinical research at the Great Ormond
`
`Street Hospital for Children in London, UK and the Emory University in Atlanta,
`
`GA. She is currently serving as the Associate Director of Clinical Research at the
`
`Departments of Surgery and Radiology at the University of Arkansas for Medical
`
`Sciences.
`
`18. As a result of my background, education, experience, and network
`
`connections and exposure, I believe that I am qualified to provide opinions from the
`
`6
`
`Petitioner Therabody Ex-1002, 0017
`
`

`

`U.S. Patent No. 12,036,174
`Declaration of Morten O. Jensen, PhD, DrMed
`standpoint of the person of skill in the art relating to the design and performance of
`
`the technology described in the '174 patent and the prior art references that I discuss
`
`in this Declaration.
`
`B. MATERIALS CONSIDERED
`19.
`In forming my opinions, I reviewed the following documents, in
`
`addition to others I have cited in my declaration. I also relied on my own knowledge
`
`of and experience in the field of biomedical engineering.
`
`Ex. No.
`
`Description
`
`Ex-1001 U.S. Patent No. 12,036,174 (“the ’174 Patent”)
`
`Ex-1002 Declaration for Morten O. Jensen
`
`Ex-1003 Curriculum Vitae of Morten O. Jensen
`
`Ex-1004 Prosecution History of the ’174 Patent (Application No. 18/526,980)
`
`Ex-1005 Korean Unexamined Application Publication No. 10-2001-0008111 (“Lee”)
`
`Ex-1006 Certified Translation of Korean Unexamined Application Publication No.
`10-2001-0008111 (“Lee”)
`
`Ex-1007 U.S. Patent Application Publication No. 2016/0310353 (“Barasch”)
`
`Ex-1008 Korean Patent No.10-1123926 (“Choi”)
`
`Ex-1009 Certified Translation of Korean Patent No.10-1123926 (“Choi”)
`
`Ex-1010 U.S. Patent No. 7,384,405 (“Rhoades”)
`
`Ex-1011 U.S. Patent Application Publication No. 2015/0305969 (“Giraud”)
`
`Ex-1012 Chunpeng Jiang et al., A Wearable Braille Recognition System Based on
`High Density Tactile Sensors, 2020 IEEE 33rd Int’l Conf. on Micro Electro
`Mech. Sys. (MEMS) 28-31 (2020)
`
`7
`
`Petitioner Therabody Ex-1002, 0018
`
`

`

`Ex. No.
`
`U.S. Patent No. 12,036,174
`Declaration of Morten O. Jensen, PhD, DrMed
`Description
`
`Ex-1013 The Cadence Tablet, Tactile Engineering, https://www.tactile-
`engineering.com/cadence (last visited Jan. 16, 2025)
`
`Ex-1014 Devin Thorpe, These 6 Women Undergrads at MIT Invented a Game-
`Changer for the Blind, Forbes,
`https://www.forbes.com/sites/devinthorpe/2016/12/20/these-6-women-
`undergrads-at-mit-invented-a-game-changer-for-the-blind/ (Dec. 20, 2016)
`
`Ex-1015 O-Rejuv Facial Device, O Cosmedics, https://www.ocosmedics.com/o-
`rejuv-facial-device.html (last visited Jan. 16, 2025)
`
`Ex-1016 ZAQ Facial Rejuvenation Device, ZAQ, https://zaq.com/products/zaq-facial-
`rejuvenation-7-color-led-device-rf-ems-sonic-vibration-hot-massager (last
`visited Jan. 16, 2025)
`
`Ex-1017 Sooyeon Choi et al., Efficacy and Safety of a Home-Use Handheld Multi-
`Energy-Based Device for Skin Rejuvenation: Clinical, Ex Vivo, and
`Histological Studies, 39 Lasers Med. Sci. 38 (2024)
`
`Ex-1018 Ergonomics and Handheld Medical Devices: Five Vital Elements for Design
`Success, Medical Design Briefs,
`https://www.medicaldesignbriefs.com/component/content/article/%2029108-
`ergonomics-and-handheld-medical-devices-five-vital-elements-for-design-
`success (lasted visited Jan. 16, 2025)
`
`Ex-1019 Finding a Percussion Massager for Effective Muscle Recovery, Pulse
`Therapy Hub, https://pulsetherapyhub.com/the-difference-between-a-
`percussion-massager-and-a-vibration-massager (lasted visited Jan. 16, 2025)
`
`Ex-1020 Claim Correlation Chart
`
`Ex-1021 Percussion Massage v. Vibration Massage, Dr. Graeme,
`https://www.drgraeme.com/articles/2021/06/percussion-massager-vs-
`vibration-massage (lasted visited Jan. 16, 2025)
`
`Ex-1022 Vibration vs. Percussion Massagers: Which One is the